The novel mapping and ablation lattice-tip catheter (Sphere-9; Medtronic, Minneapolis, MN, USA)
1,2 can toggle between pulsed field (PF)
3 and radiofrequency (RF) energy. In pre-clinical studies, it showed promising results for ventricular tissue treatment.
4,5 However, there are no clinical studies reported for ventricular tachycardia (VT) ablation.
6